Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioPharmX Corporation BPMX

Healthcare Biotechnology
"BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated with drug therapies or drug delivery approaches that... see more

Recent & Breaking News (NYSEAM:BPMX)

BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020

PR Newswire May 15, 2020

BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting

PR Newswire May 13, 2020

BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals

PR Newswire May 8, 2020

BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 AM eastern time

PR Newswire April 27, 2020

Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials Grant

PR Newswire April 6, 2020

BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading

PR Newswire March 25, 2020

Pharma Two B Appoints David S. Tierney, M.D. as the Company's Chief Executive Officer

GlobeNewswire February 18, 2020

BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement

PR Newswire January 28, 2020

BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update

PR Newswire December 10, 2019

BioPharmX Receives Notice of Compliance Deadline Extension from NYSE American

PR Newswire September 20, 2019

BioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate Update

PR Newswire September 9, 2019

BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer

PR Newswire July 16, 2019

BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular Rosacea

PR Newswire June 25, 2019

BioPharmX Reports Fiscal First Quarter 2020 Financial Results

PR Newswire June 11, 2019

BioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea

PR Newswire May 22, 2019

BioPharmX Completes 1-for-25 Reverse Stock Split

PR Newswire April 26, 2019

BioPharmX Announces Reverse Stock Split

PR Newswire April 15, 2019

BioPharmX Announces $3.9 Million Offering

PR Newswire March 21, 2019

BioPharmX to Participate in the 31st Annual ROTH Conference and the Oppenheimer 29th Annual Healthcare Conference

PR Newswire March 18, 2019

BioPharmX Reports Fourth Quarter and Full Year 2019 Financial Results

PR Newswire March 14, 2019